IDiyas

For the Inventor, By the Inventor

Harlow, United Kingdom

David John Nash

USPTO Granted Patents = 11

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 32(Granted Patents)


Location History:

  • Little Walden, GB (1996 - 2001)
  • Harlow, GB (2007 - 2011)

Company Filing History:

goldMedal11 out of 2,198 
 
Smithkline Beecham Corporation
 patents

Years Active: 1996-2011

Loading Chart...
11 patents (USPTO):Explore Patents
1. 7928125 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-04-19),
2. 7928124 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-04-19),
3. 7897618 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-03-01),
4. 7893090 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-02-22),
5. 7470710 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2008-12-30),
6. 7405217 - N-aroyl piperazine derivatives as orexin receptor antagonists (2008-07-29),
7. 7365077 - Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor (2008-04-29),
8. 7166608 - [object Object] (2007-01-23),
9. 6274593 - Substituted tetrahydro isoquinolines as modulators of dopamine D3 receptors (2001-08-14),
10. 6143762 - Tetrahydroisoquinoline derivatives and their pharmaceutical use (2000-11-07),
11. 5523299 - 5-(2-oxyphenyl)-pyrrole derivatives as dopamine D.sub.3 receptor (1996-06-04),

Title: The Innovative Mind of David John Nash

Introduction

David John Nash, an accomplished inventor based in Harlow, GB, has made significant contributions to the field of pharmaceuticals. He holds an impressive portfolio of 11 patents, showcasing his dedication to innovation and his expertise in medicinal chemistry.

Latest Patents

Among his latest patents are the N-aroyl cyclic amine derivatives, which are recognized for their role as orexin receptor antagonists. These compounds, defined by specific molecular formulas, demonstrate potential therapeutic applications in addressing various medical conditions linked to the orexin system.

Career Highlights

David has built his career at SmithKline Beecham Corporation, a well-known name in the pharmaceutical industry. His inventions have not only contributed to his company's reputation but have also pushed the boundaries of what is possible in drug development.

Collaborations

Throughout his career, David has worked alongside talented professionals such as Geoffrey Stemp and Christopher Norbert Johnson. These collaborations highlight the importance of teamwork and shared knowledge in the pursuit of groundbreaking inventions.

Conclusion

David John Nash exemplifies the spirit of innovation in the pharmaceutical sector. With his 11 patents and continued work at SmithKline Beecham Corporation, he stands as a testament to the impact of dedicated inventors in advancing medical science. His contributions to the field not only inspire fellow inventors but also pave the way for future advancements that can improve healthcare outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…